Ftse Mib
38.499,71
0,20%
DAX
22.488,12
1,01%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
95.606,09
-0,69%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Travere Therapeutics Inc (TVTX) Travere Therapeutics Inc (TVTX) Notizie

Travere Therapeutics Inc

TVTX
22,58
0,60 (2,73%)
Pre Mercato
Ultimo aggiornamento: 11:09:59
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/2/202522:04EDGAR2Form 8-K - Current report
20/2/202522:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
14/2/202523:22EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/2/202522:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
13/2/202503:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202503:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202503:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202503:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202501:47EDGAR2Form 144 - Report of proposed sale of securities
13/2/202501:46EDGAR2Form 144 - Report of proposed sale of securities
12/2/202523:30GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
12/2/202517:03EDGAR2Form 144 - Report of proposed sale of securities
11/2/202522:08EDGAR2Form 144 - Report of proposed sale of securities
11/2/202522:04EDGAR2Form 144 - Report of proposed sale of securities
11/2/202517:56EDGAR2Form 144 - Report of proposed sale of securities
11/2/202513:05EDGAR2Form 8-K - Current report
11/2/202513:01GLOBETravere Therapeutics to Submit sNDA for FILSPARI®..
11/2/202500:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202522:21EDGAR2Form 144 - Report of proposed sale of securities
05/2/202519:23EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
05/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202502:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:11EDGAR2Form 144 - Report of proposed sale of securities
04/2/202502:47EDGAR2Form 144 - Report of proposed sale of securities
04/2/202502:46EDGAR2Form 144 - Report of proposed sale of securities
04/2/202502:41EDGAR2Form 144 - Report of proposed sale of securities
04/2/202502:40EDGAR2Form 144 - Report of proposed sale of securities
03/2/202517:22EDGAR2Form 144 - Report of proposed sale of securities
03/2/202517:11EDGAR2Form 144 - Report of proposed sale of securities
24/1/202502:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202502:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202502:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202502:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202502:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202502:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:14EDGAR2Form 144 - Report of proposed sale of securities
22/1/202516:34EDGAR2Form 144 - Report of proposed sale of securities
22/1/202515:36EDGAR2Form 144 - Report of proposed sale of securities
13/1/202513:30EDGAR2Form 8-K - Current report
13/1/202513:00GLOBETravere Therapeutics Provides Corporate Update and 2025..
06/1/202522:30GLOBETravere Therapeutics to Present at the 43rd Annual J.P...
28/12/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202422:13EDGAR2Form 144 - Report of proposed sale of securities
26/11/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202423:59EDGAR2Form 144 - Report of proposed sale of securities
25/11/202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
Apertura: Min: Max:
Chiusura: 21,98

La tua Cronologia

NASDAQ
TVTX
Travere Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci